Galera Therapeutics

Galera Therapeutics develops and commercializes novel mechanism-based therapies for the treatment of cancer.

Business Model:

Revenue: $0

Employees: 11-50

Detailed Galera Therapeutics Information

Geographic Data

Galera Therapeutics headquarters map

Address: 2 West Liberty Boulevard

City: Malvern

State: PA

Zip: 19355

Country: US

Financial Info

Stage:

series unknown

Raised Last:

$0

Raised Total:

$149M

Metrics

4,100,416Website Global Rank

2,846Website Monthly Traffic

Twitter Followers

Description

Galera Therapeutics develops and commercializes novel mechanism-based therapies for the treatment of cancer.

Contact Phone:
+16107251500

Contact Email:

Galera Therapeutics went public on 11/6/2019 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
11/6/2019

IPO Valuation:
$291M

Ticker Symbol:
GRTX

IPO Price:
$12/share

Amount Raised:
$60M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
11/2019 IPO $60M
11/2016 Series B 1 $15M Sofinnova Investments
Sofinnova Investments
10/2015 Series B 6 $37M Novo Ventures
Novartis Venture Fund
New Enterprise Associates
Galera Angels
Cultivation Capital
Correlation Ventures
Novo Ventures
12/2012 Series A 3 $11M New Enterprise Associates
Novartis Venture Fund
Correlation Ventures
New Enterprise Associates
Novartis Venture Fund
8/2018 Series C $70.2M Novartis Venture Fund
Novo Ventures
Sofinnova Ventures
9/2015 Series B $37.1M Novo Ventures
New Enterprise Associates
Novartis Venture Fund
Correlation Ventures
1/2009 Venture Round 1 - Sofinnova Investments
Sofinnova Investments
2/2016 Series B $0 Enso Ventures
St. Louis Arch Angels
Novo Ventures
Novartis Venture Fund
New Enterprise Associates
Galera Angels
Correlation Ventures
Enso Ventures
St. Louis Arch Angels
Novo Ventures
Novartis Venture Fund
New Enterprise Associates
Galera Angels
Correlation Ventures
1/2020 Venture Round 1 - Frazier Healthcare Partners
Frazier Healthcare Partners
9/2018 Series C 11 $70M HBM Healthcare Investments AG
New Enterprise Associates
Rock Springs Capital
Adage Capital Management
Tekla Capital Management
Correlation Ventures
Novartis Venture Fund
Novo Ventures
Clarus Ventures
Clarus Ventures
Sofinnova Investments
Nan Fung Life Sciences
HBM Healthcare Investments AG
New Enterprise Associates
Rock Springs Capital
Adage Capital Management
Tekla Capital Management
Correlation Ventures
Novartis Venture Fund
Novo Ventures
Clarus Ventures
Clarus Ventures
8/2014 Series A 2 $4.7M Novartis Venture Fund
New Enterprise Associates
3/2015 Series A 3 $4.7M Novartis Venture Fund
New Enterprise Associates
Correlation Ventures
9/2011 Convertible Note $405k
1/2011 Convertible Note $805k
2/2016 Series B 7 $5M Enso Ventures
New Enterprise Associates
Novartis Venture Fund
Novo Ventures
Correlation Ventures
1/2020 Venture Round 1 - Frazier Healthcare Partners
Frazier Healthcare Partners
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research